Effect of the novel functional fibre, polyglycoplex (PGX), on body weight and metabolic parameters: A systematic review of randomized clinical trials

Clinical Nutrition

Volumn 34, Issue 6, 2015, Pages 1109-1114

  Onakpoya, Igho J ^a   Heneghan, Carl J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Blood lipid; Blood pressure; Body weight; Composition; Polyglycoplex; Systematic review

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYGLYCOPLEX; POLYSACCHARIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ALGINIC ACID; BACTERIAL POLYSACCHARIDE; DRUG COMBINATION; GLUCOSE BLOOD LEVEL;

ABDOMINAL BLEEDING; ADVERSE OUTCOME; ARTICLE; BLOATING; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; DIARRHEA; DIASTOLIC BLOOD PRESSURE; FLATULENCE; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; METABOLIC PARAMETERS; NAUSEA; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION; ADMINISTRATION AND DOSAGE; BLOOD; BLOOD PRESSURE; DIETARY FIBER; DIETARY SUPPLEMENT; DRUG COMBINATION; DRUG EFFECTS; FACTUAL DATABASE; META ANALYSIS; METABOLISM; OVERWEIGHT;

ALGINATES; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DATABASES, FACTUAL; DIETARY FIBER; DIETARY SUPPLEMENTS; DRUG COMBINATIONS; HUMANS; OBESITY; OVERWEIGHT; POLYSACCHARIDES, BACTERIAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIGLYCERIDES;

EID: 84921504389     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.01.004     Document Type: Article

References (25)

1. Mitchell N.S., Catenacci V.A., Wyatt H.R., Hill J.O. Obesity: overview of an epidemic. Psychiatr Clin North Am 2011, 34(4):717-732.
2. Park A., Sifferlin A. Dieters, beware. supplements for weight loss are heavy on claims and light on scientific proof. Time 2014, 184(1):20.
3. Grover G.J., Koetzner L., Wicks J., Gahler R.J., Lyon M.R., Reimer R.A., et al. Effects of the soluble fiber complex PolyGlycoplex on glucose homeostasis and body weight in young zucker diabetic rats. Front Pharmacol 2011, 2:47.
4. Chen H.L., Cheng H.C., Liu Y., Liu S., Wu W. Konjac acts as a natural laxative by increasing stool bulk and improving colonic ecology in healthy adults. Nutrition 2006, 22:1112-1119.
5. Doi K. Effect of konjac fibre (glucomannan) on glucose and lipids. Eur J Clin Nutr 1995, 49:S190-S197.
6. Wang J.P., An H.Z., Jin Z.Y., Xie Z.J., Zhuang H.N., Kim J.M. Emulsifiers and thickeners on extrusion-cooked instant rice product. J Food Sci Technol 2013, 50(4):655-666.
7. Savvides A.L., Katsifas E.A., Hatzinikolaou D.G., Karagouni A.D. Xanthan production by Xanthomonas campestris using whey permeate medium. World J Microbiol Biotechnol 2012, 28(8):2759-2764.
8. Carabin I.G., Lyon M.R., Wood S., Pelletier X., Donazzolo Y., Burdock G.A. Supplementation of the diet with the functional fiber PolyGlycoplex is well tolerated by healthy subjects in a clinical trial. Nutr J 2009, 8:9.
9. ®) on glycemic control, insulin secretion, and GLP-1 levels in Zucker diabetic rats. Life Sci 2011, 88(9-10):392-399.
10. Grover G.J., Koetzner L., Wicks J., Gahler R.J., Lyon M.R., Reimer R.A., et al. Effects of the soluble fiber complex PolyGlycopleX on glucose homeostasis and body weight in young zucker diabetic rats. Front Pharmacol 2011, 2:47.
11. Reimer R.A., Pelletier X., Carabin I.G., Lyon M., Gahler R., Parnell J.A., et al. Increased plasma PYY levels following supplementation with the functional fiber PolyGlycopleX in healthy adults. Eur J Clin Nutr 2010, 64(10):1186-1191.
12. Jenkins A.L., Kacinik V., Lyon M., Wolever T.M. Effect of adding the novel fiber, PGX®, to commonly consumed foods on glycemic response, glycemic index and GRIP: a simple and effective strategy for reducing post prandial blood glucose levels-a randomized, controlled trial. Nutr J 2010, 9:58.
13. Brand-Miller J.C., Atkinson F.S., Gahler R.J., Kacinik V., Lyon M.R., Wood S. Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia. Eur J Clin Nutr 2010, 64(12):1488-1493.
14. Brand-Miller J.C., Atkinson F.S., Gahler R.J., Kacinik V., Lyon M.R., Wood S. Effects of added PGX®, a novel functional fibre, on the glycaemic index of starchy foods. Br J Nutr 2012, 108(2):245-248.
15. Jenkins A.L., Jenkins D.J., Wolever T.M., Rogovik A.L., Jovanovski E., Bozikov V., et al. Comparable postprandial glucose reductions with viscous fiber blend enriched biscuits in healthy subjects and patients with diabetes mellitus: acute randomized controlled clinical trial. Croat Med J 2008, 49(6):772-782.
16. List of Dietary Fibres Permitted for Use in Foods Available for Sale in Canada Bureau of Nutritional Sciences, Food Directorate, Health Products and Food BRANCH 2013, [accessed 23.10.14]. http://www.gftc.ca/pdfs/2-listofdietaryfibresreviewedandacceptedbyhealthcanada_dec%202013.pdf.
17. Lyon M.R., Reichert R.G. The effect of a novel viscous polysaccharide along with lifestyle changes on short-term weight loss and associated risk factors in overweight and obese adults: an observational retrospective clinical program analysis. Altern Med Rev 2010, 15(1):68-75.
18. Higgins J.P., Altman D.G., Gøtzsche P.C., Jüni P., Moher D., Oxman A.D., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011, 343:d5928. Cochrane Bias Methods Group; Cochrane Statistical Methods Group.
19. Solah V.A., Brand-Miller J.C., Atkinson F.S., Gahler R.J., Kacinik V., Lyon M.R., et al. Dose-response effect of a novel functional fibre, PolyGlycopleX®, PGX®, on satiety. Appetite 2014, 77:72-76.
20. Kacinik V., Lyon M., Purnama M., Reimer R.A., Gahler R., Green T.J., et al. Effect of PGX, a novel functional fibre supplement, on subjective ratings of appetite in overweight and obese women consuming a 3-day structured, low-calorie diet. Nutr Diabetes 2011, 1:e22.
21. Reimer R.A., Yamaguchi H., Eller L.K., Lyon M.R., Gahler R.J., Kacinik V., et al. Changes in visceral adiposity and serum cholesterol with a novel viscous polysaccharide in Japanese adults with abdominal obesity. Obesity (Silver Spring) 2013, 21(9):E379-E387.
22. Yamaoka K., Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med 2012, 10:138.
23. Norris S.L., Holmer H.K., Ogden L.A., Fu R., Abou-Setta A.M., Viswanathan M.S., et al. Selective outcome reporting as a source of bias in reviews of comparative effectiveness 2012, [Internet], Agency for Healthcare research and quality (US), Rockville (MD), Available from:, [accessed 10.07.11]. http://www.ncbi.nlm.nih.gov/books/NBK100613/.
24. Christley R.M. Power and error: increased risk of false positive results in underpowered studies. Open Epidemiol J 2010, 3:16-19.
25. Lundh A., Sismondo S., Lexchin J., Busuioc O.A., Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev 2012, 12:MR000033.